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Development of biomarkers for biodosimetry
was given high priority in the consensual agreement
among countries as part of readiness for countermeasures
against the possibility of a terroristic attacks using
radiological and nuclear devices1. One perspective
and non-invasive approach is to find dose-dependent
reliable and sensitive markers or altered protein
expression in epithelial cells such as enterocytes.
At cell level, pathological changes in a
gastrointestinal tract epithelium have been described
even after irradiation by sub-threshold doses. Those
changes such as flattening of the width of enterocytes,
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ABSTRACT
Previously the higher phospho-ELK-1 (p-ELK-1) expression in enterocytes 24-96 h after
sub-lethal irradiation was measured. Therefore, purpose of this study is to examine in vivo
expression of this common ERK1/2 and JNK/SAPK target during the first hours after low-dose
irradiation to assess ability of this transcriptional factor as a biodosimetric marker after the single
whole-body irradiation. The laboratory rats were randomly divided into 12 groups and irradiated
with whole-body gamma radiation dose of 0.25 Gy, 0.5 Gy, and 1.0 Gy. Samples of jejunum  were
taken 1 h, 2 h, 4 h, and 24 h later, the p-ELK-1 was immunohistochemically detected and then
its expression was measured by computer image analysis. A significantly increased expression
of p-ELK-1 in enterocytes was measured  1 h, 2 h, and 4 h after 0.5 Gy and 1.0 Gy irradiation,
24 h after all radiation doses, respectively. Peak of p-ELK-1 expression was observed at 0.5 Gy
at all time points after irradiation. The detection of p-ELK-1 might be considered as a perspective
qualitative in vivo biodosimetric marker for military purposes expressed by proliferative cells
24 h after irradiation with doses from 0.25 Gy to 1.0 Gy.
 Keywords: Radiation, biodosimetry, phospho-ELK-1, image analysis, immunohistrochemistry, biomarkers
depletion of enterocytes, etc. are compensable2,3.
Recent in vitro studies presented that alterations
of signal transduction pathways would have a
biodosimetric impact and they would be more sensitive
than classic histopathologic patterns4.
Radiation-induced DNA damage leads to G2/M
cell cycle arrest of proliferative cells5. G2/M arrest
is attributed to ERK 1/2 pathway6. Common direct
member of ERK 1/2 and JNK/SAPK mitogen-
activated protein kinases (MAPK) pathways, the
ELK-1 protein7, is activated by phosphorylation8
on site of its serine 383 and subsequently binds
DNA repair protein genes such as XRCC19.
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Narang and Krishna10 observed phospho-ELK-1
( p-ELK-1) expression in irradiated liver. They found
higher p-ELK-1 expression during the first 24 h by
the dose of 3.0 Gy and a dose-dependent expression
in the range 0.5 Gy-5.0 Gy after 4 h after single-
dose irradiation. Their results also showed gradually
increased phospho SAPK expression during the
first day, which peaked after 0.5 Gy irradiation,
while the second ELK-1 activating pathway member,
ERK 2, was overexpressed during 0.5 h - 4 h
without dose-dependency trends.
In addition, p-ELK-1 is overexpressed in irradiated
cells with proliferative activity. As published previously3,
this protein was detected in irradiated enterocytes
in vivo, unlike in fibroblasts, fibrocytes and blood
cells. Therefore, p-ELK-1 production is linked to
proliferative cells.
Previously, a significantly higher expression of
the phosphorylated form of ELK-1 was found in
irradiated rat jejunum and colon transversum lasting
up to 96 h after the whole-body single dose of 1.0
Gy - 5.0 Gy gama irradiation.
Above-mentioned facts led to investigate
phosphorylated ELK-1 expression in irradiated
enterocytes in vivo during the first day after low-
dose irradiation and its potential impact in field
biodosimetry.
2. MATERIAL AND METHODS
Male Wistar rats (Konarovice, Czech Republic)
aged 12-16 weeks weighing 250-300 g were given
a whole-body irradiation performed in a jig using
60Co unit (Chisotron, Chirana Company, Czech Republic)
at a dose rate of 0.95 Gy.min-1 with a target distance
1 m. The animals were slightly anaesthetised before
irradiation using a mixture of one volume of Rometar
(Spofa Comapany, Prague, Czech Republic), three
volumes of Narkamon (Zentiva Company, Prague,
Czech Republic) in 12 volumes of physiologic saline.
This solution was injected intramuscularly at
10 mg.kg-1.
Four groups of rats were used irradiated by
the single dose of 0.25 Gy, 0.5 Gy, 1.0 Gy, and
sham-irradiated control group. Irradiated rats were
then examined 1 h, 2 h, 4 h, and 24 h after irradiation
in subgroups consisting of 10 animals.
2.1 Histological Examination
Rats were killed by cervical dislocation and
central parts of colon transversum were carefully
fixed with a 10 per cent neutral buffered formalin.
Samples were subsequently embedded into paraffin
and 1 µm thick tissue sections were cut and Gram´s
staining for bacteria and also immunohistochemic
detections for phosphorylated ELK-1 were provided.
Immunohistochemical detection of phosphorylated
ELK-1 was performed with a standard peroxidase
technique. After blocking the endogenous peroxidase
activity for 20 min, the tissue sections were incubated
for 1 h with a monoclonal antibody recognising
p-ELK-1 (Cell signaling, Prague, Czech Republic)
diluted 1:200 in phosphate buffered saline (PBS, pH
7.2) and then washed three times in PBS. All slides
were then incubated for 45 min with biotinylated anti-
mouse antibody (Biogenex, Prague, Czech Republic)
diluted 1:200 in PBS. Subsequently, all slides were
incubated with streptavidin horseradish peroxidase
(Biogenex, Prague, Czech Republic) under the same
conditions as the secondary antibody. Excess antibodies
were then washed off with PBS. Finally, 0.05 per cent
3,3´-diaminobenzidinetetrahydrochloride-chromogen solution
(Sigma, Prygue, Czech Republic) in PBS containing
0.02 per cent hydrogen peroxide was added for 10
min to visualise the antigen-antibody complex in situ.
2.2 Image Analysis
Stained samples were evaluated using the
BX-51 microscope (Olympus, Prague, Czech Republic)
and computer image analysis ImagePro 4.11 (Media
Cybernetics, MD, USA). Six microscopic fields at
a 400 fold original magnification were ramdomly
selected from each rat sample.
The p-ELK-1 immuno-reactive structures were
detected in the inverted RGB range: red 100-255,
green 171-255, and blue 161-255, where 0 is white
and 256 is black colour. Subsequently, integral optical
density, density mean (of positive objects), and
percentage of positive stained areas of viewing
fields were measured.
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2.3 Data Processing
The Mann-Whitney test was used for the statistical
analysis giving mean ± 2 x SEM (Standard error
of mean).
3 . RESULTS
No animal died prior to the time of examination
and no infectious agents were found. In the central
parts of colon transversum, positively stained cytoplasm
of enterocytes and goblet cells were seen.
In comparison to values of non-irradiated animals,
a significantly higher density means of phospho-
ELK-1 were measured in colon transversum of all
rats irradiated by the doses of 0.5 Gy and 1.0 Gy
except the group examined 4 h after 1.0 Gy irradiation.
During 24 h after irradiation, a dose-dependency
of p-ELK-1 expression measured as density means
of immuno-reactive objects was not observed (Table 1).
Significantly higher values of the p-ELK-1
expression in per cent were measured in animals
examined 24 h after 0.25 Gy irradiation as well as
in all animals irradiated with 0.5 Gy and 1.0 Gy
than in non-irradiated rats except the group examined
4 h after 1.0 Gy irradiation. A dose dependency
of p-ELK-1 expression after irradiation in the range
of 0.25 to 0.5 Gy was observed 24 h after irradiation
(Table 2).
During the measurement of the integral optical
density, it was found that behaviour of irradiated
enterocytes is similar to that of the density means
of p-ELK-1 (Table 3).
4 . DISCUSSION
ELK-1 is a transcription factor which activates
by several MAPK, it is involved in ERK 1/2 and
JNK/SAPK pathways conducting the immediate
early responses of the c-FOS promoter to ionising
radiation. ELK-1 is a component of the ternary
complex that binds the serum response element
(SRE) in response to serum11. ELK-1 is inducible
by pro-inflammatory cytokine cascade member
Interleukine-1 beta12 and growth factors such as
vascular endothelial growth factor13 and epidermal
growth factor14, which are up-regulated after irradiation
in vivo. This protein might be also activated by 
Radiation dose 0 Gy Radiation dose 0.25 Gy Radiation dose 0.5 Gy Radiation dose 1.0 Gy 
1 h post-irradiation  45.3±4.5 128.2±7.6***,+++ 132.7±5.4*** 
2 h post-irradiation  26.0±2.7 130.9±6.8***,+++ 137.1±6.5*** 
4 h post-irradiation  40.3±4.7 157.5±7.6***,+++ 63.3±4.4+++ 
24 h post-irradiation 59.5±6.2 111.6±6.9*** 162.6±7.4***,+++ 151.4±7.1*** 
Significant differences among animals sham-irradiated (0 Gy) and animals irradiated by the dose of 0.25 Gy-1.0 Gy: p < 0.05 - *; p < 0.01 - **;  
p < 0.001 - ***. 
Significant differences between values of irradiated animals to animals irradiated by the neighbouring lower dose: p < 0.05 – +; p < 0.01 – ++;  
p < 0.001 – +++. 
 
Table 1. Average values of p-ELK-1 positive structures density means per microscopic field ± SEM 
Radiation dose 0 Gy Radiation dose 0.25 Gy Radiation dose 0.5 Gy Radiation dose 1.0 Gy 
1 h post-irradiation  1.28±0.17 10.15±1.00***,+++ 8.36±0.54*** 
2 h  post-irradiation  0.60±0.10 9.28±0.90***,+++ 8.66±0.58*** 
4 h  post-irradiation  1.44±0.24 14.9±1.22***,+++ 1.95±0.24+++ 
24 h  post-irradiation 3.57±0.56 4.15±0.34*** 25.15±1.54***,+++ 10.01±0.94***,+++ 
Significant differences among animals sham-irradiated (0 Gy) and animals irradiated by the dose of 0.25 Gy-1.00 Gy: p < 0.05 - *; p < 0.01 - **;  
p < 0.001 - *** 
Significant differences between values of irradiated animals to animals irradiated by the neighbouring lower dose: p < 0.05 – +; p < 0.01 – ++;  
p < 0.001 – +++ 
Table 2. Average value of p-ELK-1 positive structures in per cents per microscopic field (field area is 100 %) ± SEM
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other stress stimuli such as hyperosmolarity15. An
early ELK-1 activation after radiation-induced DNA
damage leads to higher cell proliferation and higher
resistency to apoptosis probably via action of anti-
apoptotic MCL-111, whereas persisting activation
has link to G2/M cell cycle arrest and/or apoptosis.
Suzuki4, et al. sugested that apoptosis seen in MAPK
active condition after irradiation is due to p53
accumulation, which was not detected at doses up
to 0.5 Gy, while between 1.0 Gy and 6.0 Gy, the
level of p53 protein increased in a dose-dependent
manner. This suggestion supports Lee,15 et al.,
who observed acceleration of apoptotic pathway
after inhibition of ERK1/2 activity.
In this study, expression of ELK-1 phosphorylated
was measured by MAP kinase 1 predominantly at
serine 383, although MAP kinase 1 can also phosphorylate
Elk-1 at serine 324, 389, and 422 and at threonine
33616. It is not still clear whether ELK-1 phosphorylation
at different site than serine 383 regulates different
mechanisms.
From results it follows, that the p-ELK-1 saturation
was observed during the first 4 h and during the
24 h after irradiation by a dose of 0.5 Gy and
0.25 Gy respectively. For better clarity of p-ELK-1
action it is crucial to answer why p-ELK-1 activation
in enterocytes is lower after sub-lethal and lethal
irradiation. One of possible reasons could be low
fraction of enterocytal stem cells or activation of
different pathways after serious DNA damage4, 17.
However, generally lower p-ELK-1 expression was
observed in low-differentiated cells localised between
mucous plicas than in mature and well-differentiated
cells at the top of mucous plicas.Therefore,
p-ELK-1 expression might be directly dependent
on cell differentiation and for practical biodosimetric
evaluation it should be measured in the most differentiated
part of mucosa. Probable explanation was published
by Townsend18, et al., who measured proliferative
and differentiation effect of MCL-1, the ELK-1-
mediated protein, to immature monocytes is that
ELK-1-mediated up-regulation of MCL-1 through
mechanisms similar to those utilised by c-FOS,
EGR1, NUR77, and others might aid in maintaining
viability as these cells move along the differentiation
pathway. Therefore, consequences of ELK-1 up-
regulation in irradiated cells might be strong differentiation
as well as proliferation factor mobilising pool of
surviving stem cells to compensate low number of
enterocytes after irradiation.
The early response mechanism may also serve
to restrict MCL-1 expression to specific windows
of time (e.g., the initiation of a step forward in
differentiation), preventing prolonged exposure of
cells to the viability-promoting gene product and
minimising the possibility of transformation18.
Biodosimetric abilities of p-ELK-1 enhances
results published by Sautin19, et al., when ELK-1
activation did not change significantly in Clostridium
difficile toxin-treated murine hepatocyte cell line
AML12. Otherwise, bacteria themselves such as
Staphylococcus aureus, provide time- and dose-
dependent ERK1/2 activation. Therefore, in irradiated
patients, it is necessary to exclude ELK-1 activation
due to any other microbial and physical stress stimulation.
In addition, p-ELK-1 expression is more sustainable
than for example p53 accumulation. Previously, p-
ELK-1 positive enterocytes were detected even 96 
Radiation dose 0 Gy Radiation dose 0.25 Gy
 
Radiation dose 0.5 Gy Radiation dose 1.0 Gy 
1 h  post-irradiation  407±55 3433±351***,+++ 2788±186*** 
2 h  post-irradiation  207±39 3106±307***,+++ 2858±198*** 
4 h  post-irradiation  457±77 5069±425***,+++ 630±78+++ 
24 h  post-irradiation 1141±163 1385±113 8486±526***,+++ 3249±304***,+++ 
Significant differences among animals sham-irradiated (0 Gy) and animals irradiated by the dose of 0.25 Gy-1.0 Gy: p < 0.05 - *; p < 0.01 - **;  
p < 0.001 - *** 
Significant differences between values of irradiated animals to animals irradiated by the neighbouring lower dose: p < 0.05 – +; p < 0.01 – ++;  
p < 0.001 – +++ 
Table 3. Average value of integral optical density of p-ELK-1 positive structures per microscopic field ± SEM
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h after 1.0 Gy and 5.0 Gy irradition, otherwise p53
accumulation with subsequent phosphorylation at
serine 15 was observed during the first day within
3 h after irradiation20. A higher and prolonged
expression of ELK-1 in irradiated enterocytes might
be linked to enhanced stimulation of stem cells to
compensate diminished number of mature enterocytes
after irradiation until this cell population would
reach a sufficient number that allows them to restore
and keep all functions. Therefore, ELK-1 up-regulation
can be measured even 96 h after sub-lethal irradiation.
On basis of in vivo results, it is suggested:
(a) p-ELK-1 activation is strongly linked to radiation
response of proliferating cells, and
(b) Viable biodosimetric ‘window’ is 24 h after
single 0.25 Gy - 5.00 Gy gamma irradiation due
to sustainability of p-ELK-1 expression.
The detection of p-ELK-1 might be considered
as a suitable qualitative biodosimetric marker of
proliferative cells useful under clinical conditions.
In military field conditions should be used more
accessable proliferating cell line such as keratinocytes
or epithelial cells from cavum oris. However, this
suggestion has to be verified by further experiments
detecting the p-ELK-1 expression in other tissues
and after other agents than ionising radiation, which
can be produced by weapons of mass destruction,
namely nervous paralytic compounds and lethal
infections.
5 . CONCLUSIONS
Significantly increased expression of p-ELK-1
in rat colon transversum 24 h after sub-lethal irradiation
has been observed and subsequent experiments
including preparation of ELISA (the most suitable
military field molecular biologic technique) calibration
curves of human samples as rectal smears might
be conducted.
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